Share of first-cycle novel drug approvals
Percentage of novel drug approvals granted on the first regulatory review cycle.
Unit Percent Industry Pharmaceuticals
Records
1
Regions
1
Period
2024
Sources
1
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
All records
1 record · 1 region · 2024
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024 | FDA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Share of first-cycle novel drug approvals. Retrieved from https://statorigin.org/indicators/share-of-first-cycle-novel-drug-approvals